MR. RONALD JOSEPHY GOLUBSKI R.PH.
Prescription History 1174741706
Pharmacist in Truth Or Consequences, NM

NPI Status: Active since April 20, 2007

Contact Information

500 N BROADWAY ST
TRUTH OR CONSEQUENCES, NM
ZIP 87901
Phone: (505) 894-1079
Fax: (505) 894-0585

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MR. RONALD JOSEPHY GOLUBSKI R.PH., an active Pharmacist specialist practicing in Truth Or Consequences, NM. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 121 documented patient claims. Among these therapy options, the most frequently utilized medication is Abrysvo, which accounts for 65 claims alone.

Medication Index

No matching medications currently found on file.

Abrysvo

Generic Formulation: Rsv Vacc, Pref A And Pref B/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 65
30-Day Fills 65.0
Days Supply 65
NM State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$330.52

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Shingrix

Generic Formulation: Varicella-Zoster Ge/As01b/PfSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 56
30-Day Fills 56.0
Days Supply 56
NM State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills43.8
Peer Average Days Supply55
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 30.2% more claims than the standard regional baseline profile for NM. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,149.38 across this reporting matrix range.

Provider Avg Cost Per Claim

$199.10

State Avg Cost Per Claim

$198.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MR. RONALD JOSEPHY GOLUBSKI R.PH. provides transparency into local medical care patterns within Truth Or Consequences, NM.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pharmacist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.